ClearNote Health (formerly Bluestar Genomics) – Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives.

They focus on developing non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. They apply their proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based changes in biology as cancer develops.

With lead programs in non-invasive early detection of pancreatic and ovarian cancers in patients at the highest risk for these diseases. Headquartered in the U.S, the company’s CLIA and CAP-accredited laboratory is located in San Diego, Calif., with additional presence in the San Francisco Bay Area and internationally.


Biotechnology

Clearnote Health

Dave Mullarkey

Danielle Scelfo

Gulfem D. Guler

Anna Bergamaschi

Eric Nilson

Samuel Levy

Wayne Volkmuth

Jim Vaughn

The Clinical Research Team at Clearnote Health is responsible for designing and conducting clinical studies to validate the efficacy and safety of the company's non-invasive cancer detection tests. They oversee patient recruitment, data collection, and analysis, while ensuring compliance with regulatory standards. By collaborating with cross-functional teams, they aim to translate scientific discoveries into actionable medical solutions for early cancer detection.

Clinical Research Team

Scientists Team

Advisory Team

Clinical Research Team

About

Team members

Other teams at Clearnote Health

Scientists Team

Advisory Team